Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Cash from Operations (2020 - 2025)

Ovid Therapeutics' Cash from Operations history spans 6 years, with the latest figure at 10374000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 3.66% year-over-year to 10374000.0; the TTM value through Dec 2025 reached 38300000.0, up 31.55%, while the annual FY2025 figure was 38300000.0, 31.55% up from the prior year.
  • Cash from Operations reached 10374000.0 in Q4 2025 per OVID's latest filing, up from 12872000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 160899083.0 in Q1 2021 to a low of 20086419.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 3832622.7, with a median of 11954752.0 recorded in 2021.
  • The largest YoY upside for Cash from Operations was 973.89% in 2021 against a maximum downside of 639.88% in 2021.
  • A 5-year view of Cash from Operations shows it stood at 11998504.0 in 2021, then increased by 23.53% to 9175732.0 in 2022, then fell by 29.81% to 11911000.0 in 2023, then rose by 15.98% to 10008000.0 in 2024, then fell by 3.66% to 10374000.0 in 2025.
  • Per Business Quant, the three most recent readings for OVID's Cash from Operations are 10374000.0 (Q4 2025), 12872000.0 (Q3 2025), and 4754000.0 (Q2 2025).